WUHU, China, Oct. 19, 2025 /PRNewswire/ — At the 2025 Chery Global Innovation Conference, an extraordinary “guest” took the stage — Mornine, the intelligent robot from AiMOGA Robotics.

Opening in seven languages, she completed a fully autonomous presentation, marking the moment when “Automotive + Robot” collaboration officially moved from concept to reality.

Center Stage: Autonomous Presentation Illustrates Ecosystem Advancement

Following Dr. Gao Xinhua’s keynote, Mornine appeared on stage and independently completed a full capability demonstration in just three minutes.

She reviewed AiMOGA’s journey from early concept to real-world deployment across more than 30 countries.

As Dr. Gao emphasized, this appearance signifies Chery’s technological expansion from “wheels” to a “three-dimensional ecosystem,” where intelligent robots represent a natural extension of Chery’s innovation strategy.

Technological Foundation: Robotics Grown from Automotive DNA

The technology system of AiMOGA Robotics is rooted in Chery’s vehicle-engineering platform.

From multilingual interaction (11 languages) to ±5 cm high-precision autonomous navigation and dynamic obstacle avoidance, Mornine inherits Chery’s expertise in intelligent cockpits and driver-assistance engineering.

These reusable and scenario-driven capabilities enable an end-to-end intelligent service process, allowing Mornine to perform dealership reception and extend into museums, malls, and public service scenarios as a trusted human AI assistant.

Scenario Application: From Demonstration to Real-World Practice

At the venue, Mornine completed a fully autonomous car-purchasing reception process, covering greeting, vehicle explanation, door-opening, and car-machine collaboration.

Interactive zones showcased her vision-tactile dexterous hand and multi-expression interaction system, enabling delicate object manipulation and real-time emotional expressions.

These advances mark a breakthrough in multimodal perception and human-like interaction, setting new standards for intelligent service robots.

Conclusion

The 2025 Chery Global Innovation Conference showcased AiMOGA Robotics’ achievements in language interaction, navigation control, and multimodal execution, while verifying its real-world applications in 4S dealerships.

As a key practice of Chery’s “Automotive + Robot” human-machine collaboration strategy, Mornine continues to demonstrate perceptive, executable, and deployable service capabilities—bringing embodied intelligence from the lab into daily life.

Born from the automotive industry and advancing toward real-world scenarios, AiMOGA Robotics is paving a new evolutionary path for the industry—one that connects vehicle engineering with intelligent service innovation.

HONG KONG, Oct. 18, 2025 /PRNewswire/ — The second phase of the Global Sources Hong Kong Shows opened today at AsiaWorld-Expo, running from October 18 to 21. The four-day event combines four major trade shows: the Mobile Electronics, Smart Home, Security & Home Appliances, Lifestyle, and Home & Kitchen shows under the theme “AI-Powered Ecosystem: Igniting Future Manufacturing Intelligence.” The show has attracted over 2,000 exhibitors showcasing more than 150,000 cutting-edge innovative products, including mobile devices, smart wearables, AR/VR, smart home solutions, personal healthcare products, and pet supplies. This year also features the debut of the “AI Pavilion”. The show is projected to attract over 60,000 international professional B2B buyers, with visitor numbers from emerging markets anticipated to hit a record high.

Global Sources Hong Kong Shows Phase II includes:

• Global Sources Mobile Electronics
• Global Sources Smart Home, Security & Home Appliances
• Global Sources Lifestyle
• Global Sources Home & Kitchen

John Kao, Vice President of Hong Kong Shows & Overseas Shows at Global Sources, said: “Global Sources Hong Kong Shows Phase II closely track global sourcing hotspots, positioning at the forefront of AI transformation and comprehensively showcasing innovative applications of AI technology across various electronics sectors. For global B2B buyers and industry decision-makers, this edition of Global Sources Hong Kong Shows is not just a sourcing event, but a critical opportunity to gain comprehensive insights into the future of AI hardware ecosystems and efficiently connect with top-tier supply chains.”

AI Pavilion: Seven Zones Presenting Complete Smart Hardware Ecosystem

This year’s inaugural “AI Pavilion” features over 1,200 booths, concentrating on seven major application scenarios including AI smart terminals, AI wearables, AI glasses, AI toys, AI pet products, AI personal health care, and other AI products, providing a one-stop showcase of the latest breakthroughs in AI hardware ecosystems.

1. AI+ Terminal Devices Zone: Showcases innovative products such as phones, laptops, and keyboards, utilizing on-device AI to achieve cross-device collaboration, real-time translation, and performance optimization, demonstrating technological breakthroughs in lightweight large models, real-time perception, and multi-device collaboration.
2. AI+ Wearables Zone: Focuses on the integration of AI and health management, featuring watches, earphones, and rings. The new generation of wearable devices combines sensors with AI algorithms to provide high-precision monitoring of heart rate and sleep quality, stress detection, and early health risk warnings, transforming product functions from “passive recording” to “proactive care”.
3. AI+ Glasses Zone: Covers products with different positioning from high-end professional to affordable mainstream models. 2025 has seen the industry embrace an AI glasses boom, with AI glasses extending to gaming, education, conferences and other scenarios through real-time AI photography, intelligent recognition, and multilingual translation functions. Innovative features such as gesture control and eye tracking have become key competitive factors for manufacturers.
4. AI+ Toys Zone: Showcases the latest achievements of Asian manufacturers in companion toys. Many export-oriented enterprises are precisely targeting children’s education, adult emotional companionship, babycare, and collectible toys, providing highly customized solutions centered on early education and emotional companionship user needs, comprehensively demonstrating new global market trends in “AI+ Toys”.
5. AI+ Pet Products Zone: Displays innovative products covering intelligent health monitoring, behavior recognition and emotional companionship, and fully automated cleaning and care. AI+ pet technology applications have evolved from initial function development to focusing on precision in pet health management, deepening human-pet emotional interaction, and automation of daily care processes, bringing more efficient, reassuring, and humanized experiences to pet-owning families.
6. AI+ Personal Healthcare Zone: Highlights innovative products combining sensors and AI algorithms, covering smart beauty devices, hairbrushes, lighting, and aromatherapy machines, providing global buyers with a one-stop showcase of competitive AI+ beauty care and health management solutions.
7. Other AI+ Products Zone: Displays multiple types of mobile hardware products including smart PC cases, earphones, and smart helmets, featuring intelligent cooling, adaptive noise cancellation, and industrial safety warning functions suitable for gaming, office, and industrial protection scenarios. The zone gathers various mass-producible AI terminals, including HTC partnering with Global Sources once again to establish an “AI & XR Experience Zone”, showcasing HTC VIVE technology and multiple immersive VR games, providing global buyers with one-stop supply chain resources for ODM/OEM collaboration, finished product sourcing, and technology selection.

Innovation Awards and Global Product Launches Leading Tech and Design Trends

Global Sources Innovation Awards Phase II focus on products in mobile electronics, smart home, security and appliances, and lifestyle categories, committed to recognizing innovative products that excel in practicality, cost-effectiveness, technological maturity, and market demand alignment. Simultaneously, Global Sources continues to partner with the internationally renowned “European Product Design Award (EPDA)™” to establish the “Best Product Design Award”, honoring products that stand out through innovative thinking and exceptional design. Additionally, to align with the show theme, a special “AI Innovation Award” has been introduced to recognize exhibits demonstrating outstanding AI technology applications.

Phase II shows will also host multiple new product launch events. Many exhibitors will use this platform to unveil their annual new products, including heavyweight products making their global or Asian debuts. These new products embody the “technology + demand” integrated innovation model, showcasing the future development path and market trends of consumer electronics.

Industry Experts Gather to Explore AI-Enabled Applications

The Global Sources Summit and AI & Robotics Summit (AIRS), held during the shows with the theme “Consumer AI Gadget Conference”, brings together top global industry experts across multiple frontier fields including trillion-dollar market transformation, Asian market channel strategies, Robotics-as-a-Service, smart wearable devices, AI assistive devices, Smart Home 2030, and AI and robotics commercialization paths. The summits provide audiences with a platform for deep insights into the latest AI smart product trends and identifying high-growth potential markets, helping enterprises and investors seize key opportunities in the AI consumerization wave. The venue also features an AI robot demonstration area where visitors can experience human-robot interaction and live demonstrations up close, including the Engine AI that previously danced with internet celebrity IShowSpeed, performing the iconic Axe Gang dance from the movie “Kung Fu Hustle”, demonstrating advanced capabilities in motion planning and real-time control, and exploring prospects for robotics applications.

GSOL 30th Anniversary Celebration: Celebrating Milestones with the Industry

To celebrate the 30th anniversary of GlobalSources.com, Global Sources is hosting a special “GSOL 30th Anniversary Cocktail Party” during the shows to review the online sourcing platform’s historical journey over three decades with industry partners and key customers. The event will feature sharing from Mr. Hu Wei, CEO of Global Sources, and Ms. Carol Lau, Senior Vice President, Client Service, Marketing & Analytics, on the company’s future development blueprint, jointly witnessing the outstanding achievements of Global Sources’ B2B international sourcing platform in connecting global buyers, partners and Asian suppliers over 30 years.

About Global Sources

Global Sources is an internationally recognized multichannel Online-to-Offline (O2O) sourcing platform that has been driving global trade for over 50 years. The company connects authentic buyers and verified suppliers worldwide with tailored solutions and trusted market intelligence through its online platform GlobalSources.com, mobile apps, industry-specific trade shows, and tailored business matching. Global Sources’ unique services have successfully provided efficient and convenient commercial services to over 14 million registered international buyers and users.

This press release is distributed by Market Hubs Holdings Limited.

WUHU, China, Oct. 18, 2025 /PRNewswire/ — On October 18, 2025, the 2025 Chery Global Innovation Conference officially kicked off under the theme “Innovation • Leading the World with Intelligence.” The conference systematically presented Chery Group’s latest achievements in electrification, connectivity, intelligence, and sharing. Powered by “innovation,” the event created a technological feast that drives brand breakthroughs and connects the global ecosystem, fully demonstrating Chery’s global competitiveness and new future vision forged through global co-creation, sharing, and symbiosis.

Academicians from the Chinese Academy of Engineering, the European Academy of Sciences, the Canadian Academy of Sciences, the Canadian Academy of Engineering, and the Georgian National Academy of Sciences, along with association leaders, media representatives, government officials, and industry partners, gathered at the event. Together with global online audiences, they witnessed Chery embark on a new journey of technological globalization.

Becoming a Global High-Tech Ecological Group Loved and Trusted by Users

Building upon its strong technological foundation, Chery Group has achieved powerful breakthroughs across multiple sectors, marking five historic milestones in sales volume, new energy vehicles, exports, brand influence, and capital markets.

On September 25, Chery Automobile was officially listed on the Main Board of the Hong Kong Stock Exchange, launching a new chapter in international capital markets.

By the end of September, Chery Group had accumulated over 17.72 million global users, including more than 5.43 million overseas customers.

This “qualitative leap” of multidimensional growth stems from 28 years of continuous effort and “quantitative accumulation” in the field of technology.

At the conference, Mr. Yin Tongyue, Chairman of Chery Group, stated that globalization should not only pursue scale and speed — sustainability is key.

By establishing a global innovation system covering new energy vehicles, intelligence, and AI, Chery aims to continuously elevate its brand and achieve sustainable internationalization.

Through technological innovation, Chery will empower product innovation, drive business model, corporate management, and industrial ecosystem upgrades, transforming itself from a traditional automaker into a global high-tech ecological group.

Innovation Engine in Motion: Accelerating from Internationalization to Globalization

Innovation has always been Chery’s core driving force for breakthroughs and self-transcendence.

At the conference, Dr. Gao Xinhua, Executive Vice President and CTO of Chery Automobile Co., Ltd., announced that Chery has established a globally oriented technological innovation system — evolving from an “explorer” into a global leader in new energy.

During the event, Chery unveiled 10+ world-leading technologies, including the Smart Digital Chassis, Amphibious System, Chery Power with 48% Thermal Efficiency, Intelligent Driving Large Model, and Flying Platform, among others.

These breakthroughs have built a world-class innovation ecosystem, helping the Chinese automotive industry continuously expand its global influence.

The remarkable debut of the AiMOGA Robot further embodied Chery’s spirit of innovation.

With capabilities such as semantic interaction, autonomous obstacle avoidance, emotion recognition, and basic learning, AiMOGA is designed to become a “trustworthy intelligent assistant for humans,” marking a transformative leap toward Chery’s all-scenario intelligent ecosystem.

Venturing into the “No Man’s Land” of Innovation: Disruptive Power with Hardcore Technology

Technology is the cornerstone of Chery Group’s development. In facing core technological challenges, Chery remains steadfast in its long-term commitment to innovation.

The Chery Power with 48% thermal efficiency, showcased at the conference, is a testament to this disruptive innovation power.

While mainstream engines typically achieve thermal efficiency between 38% and 45%, every 1% improvement is a major challenge.

Through innovations such as a 26:1 ultra-high expansion ratio and a dual-curve triple-link mechanism, Chery achieved a genuine 48% thermal efficiency for gasoline engines.

In the future, Chery Group plans to promote the Chery power and other cutting-edge technologies globally, bringing users a green, efficient, and intelligent mobility experience.

Building a Global Innovation System and a New Industrial Ecosystem

While mastering core technologies, Chery Group continues to build a globally oriented innovation system.

Its products are sold in over 120 countries and regions, with 16 KD factories worldwide. Chery has also established a global collaborative innovation network that includes 8 major R&D centers, over 30,000 R&D personnel, and 28 chief scientists.

By tailoring its research and testing to diverse driving environments worldwide, Chery delivers world-class technologies suitable for global users and has successfully created a globally integrated innovation framework.

At the conference, Mr. Zhang Shengshan, Deputy General Manager of Chery Automobile and Executive Deputy General Manager of Chery International Business Division, revealed that Chery plans to establish 26 overseas R&D centers over the coming years.

This expansion will strengthen local market competitiveness, ensure regulatory compliance, and enhance localized development capabilities — creating differentiated, competitive products tailored to regional user needs.

In doing so, Chery sets a replicable innovation model for China’s automotive industry to advance from “global participation” to “global leadership.”

The 2025 Chery Global Innovation Conference is not only a stage for showcasing Chery’s technological vision and latest achievements but also a global dialogue and open invitation to cooperation.

In the future, Chery Group will accelerate its transformation into a global technology company, leveraging its worldwide innovation system to create greater mobility value for users and write a new chapter in the century-long automotive Industry.

LUOYANG, China, Oct. 18, 2025 /PRNewswire/ — On October 17, the 6th International Ancient Capitals Forum kicked off in Luoyang City, Henan Province. The event was attended by more than 150 participants, including government officials, experts and scholars, and international organization representatives from 30 countries such as the United Kingdom, France, the United States, Brazil, Egypt, Jordan, Cambodia, Singapore, and Thailand.

Under the theme of “Ancient Capitals•New Vitality: Sustainable Development of Global Ancient Capital Cities”, the forum comprises two sub-topics: Urban Renewal and Cultural Inheritance in Ancient Capitals, along with Industrial Development and New Economic Drivers in Ancient Capitals. Guests immersed themselves at the digital cinema at Dahehui, and engaged in the elegant gathering activity for cultural and creative products of intangible cultural heritage featuring Luoyang palace lanterns, Luoyang embroidery, pressed peony flowers, fried tea of the Tang Dynasty, and tri-colored murals. They also paid on-site visits to tourist attractions such as Luoyi Ancient City, Yingtianmen Scenic Area, and Longmen Grottoes. Through a series of engaging activities, they gained an in-depth understanding of Luoyang’s initiatives and achievements in cultural heritage protection and utilization, jointly delving into innovative pathways and global cooperation mechanisms for the sustainable development of ancient capitals.

Luoyang, as one of the cradles of Chinese civilization and the eastern starting point of the Silk Road, boasts a profound historical and cultural heritage. In recent years, the city has boosted tourism development through archaeological excavations and protection projects, staying committed to building itself into a world-class tourist destination. Attending guests noted that hosting this forum will contribute to the transformation of Luoyang’s practical experience into shareable solutions, thereby exploring new pathways for the sustainable development of ancient capitals worldwide through international cooperation.

The International Ancient Capitals Forum has been successfully held for five sessions. It has gradually evolved into a pivotal platform for fostering exchanges and mutual learning among civilizations.

CHENGDU, China, Oct. 18, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱^®) in previously treated locally advanced or metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 -negative (HER2-) breast cancer (BC) was presented as an oral report by Professor Man Li from the Second Affiliated Hospital of Dalian Medical University (Presentation # LBA23, Proffered paper session 1: Breast cancer, metastatic). Previously, the new indication applications for sac-TMT for this indication was accepted by the National Medical Products Administration (NMPA) and was included in the priority review and approval process.

In the OptiTROP-Breast02 study, a total of 399 patients with HR+/HER2- BC who had progression on CDK4/6 inhibitors and received at least one prior line of chemotherapy in the advanced/metastatic setting were randomized (1:1) to receive sac-TMT or investigator’s choice of chemotherapy (ICC).

As at the data cut-off date January 22, 2025, the median PFS was significantly longer in sac-TMT than in ICC (8.3 vs. 4.1 months; HR, 0.35; 95% CI, 0.26-0.48; P<0.0001). Clinical benefit was seen in sac-TMT independent of HER2 expression (HR for PFS in HER2-zero: 0.39, 95% CI, 0.26-0.57; in HER2-low: 0.31, 95% CI, 0.20-0.48).

Sac-TMT showed longer DoR versus chemotherapy; and ORR was also superior with sac-TMT to ICC.

There was a trend in OS that favored sac-TMT over ICC (HR, 0.33; 95% CI, 0.18-0.61).

Grade ≥ 3 TRAEs occurred in 62.0% and 64.8% of patients in sac-TMT and ICC. TRAE led to discontinuation in 0% and 0.5% of patients; pneumonitis occurred in 1.5% and 1.0% of patients (all grade 1-2) in sac-TMT and ICC, respectively.

As a conclusion, sac-TMT demonstrated statistically significant and clinically meaningful improvement in PFS compared to chemotherapy. PFS benefit was observed across all predefined subgroups and independent of HER2 status. Sac-TMT also showed a trend toward OS benefit (HR, 0.33; 95% CI, 0.18, 0.61) and demonstrated a favorable and manageable safety profile, with no new safety signals. Currently, a Phase III clinical study of sacituzumab tirumotecan as monotherapy and in combination with pembrolizumab in patients with chemotherapy-naïve HR+/HER2- breast cancer is ongoing globally, with a planned enrollment of approximately 1,200 participants. Additionally, another Phase III registrational study in the same population is currently enrolling patients in China, with a planned enrollment of 430 participants.

Professor Man Li from the Second Affiliated Hospital of Dalian Medical University, stated：”The Phase III OptiTROP-Breast02 study confirmed that, regardless of HER2 expression status, sac-TMT demonstrated promising efficacy in previously treated HR+/HER2- BC patients. As the first Phase III clinical trial focusing exclusively on an all-Chinese population with HR+/HER2- BC, the presentation of the OptiTROP-Breast02 study data at ESMO marks a significant breakthrough in clinical research in this indications in China. The positive outcomes of this study not only provide evidence-based support for the treatment of HR+/HER2- BC but also offer a safe and reliable new treatment option for breast cancer patients.”

About sac-TMT (佳泰莱^®)

Sac-TMT, a core product of the Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, BC, GC, gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor with a drug-to-antibody-ratio (DAR) of 7.4. Sac-TMT specifically recognizes TROP2 on the surface of tumor cells by recombinant anti-TROP2 humanized monoclonal antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable, it can enable a bystander effect, or in other words kill adjacent tumor cells.

In May 2022, the Company licensed the exclusive rights to MSD (the tradename of Merck & Co., Inc, Rahway, NJ, USA) to develop, use, manufacture and commercialize sac-TMT in all territories outside of Greater China (which includes Mainland China, Hong Kong, Macao and Taiwan).

To date, three indications for sac-TMT have been approved and marketed in China for the treatment of adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who have received at least two prior systemic therapies (at least one of them for advanced or metastatic setting), EGFR mutation-positive locally advanced or metastatic non-squamous NSCLC following progression on EGFR-TKI therapy and platinum-based chemotherapy and EGFR mutant-positive locally advanced or metastatic non-squamous NSCLC who progressed after treatment with EGFR-TKI therapy. Sac-TMT is the first TROP2 ADC drug approved for marketing in lung cancer globally. In addition, the new indication applications for sac-TMT for the treatment of adult patients with unresectable locally advanced, metastatic HR+/HER2- BC who have received prior endocrine therapy and other systemic treatments in the advanced or metastatic setting was accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), and was included in the priority review and approval process.

As of today, the Company has initiated 9 registrational clinical studies in China. MSD has initiated 15 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or with pembrolizumab or other anti-cancer agents for several types of cancer. These studies are sponsored and led by MSD.

About Kelun-Biotech

Kelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical (002422.SZ), which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. The company focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. The Company is committed to becoming a leading global enterprise in the field of innovative drugs. At present, the Company has more than 30 ongoing key innovative drug projects, of which 4 projects have been approved for marketing, 1 project is in the NDA stage and more than 10 projects are in the clinical stage. The company has established one of the world’s leading proprietary ADC and novel DC platforms, OptiDC™, and has 2 ADC project approved for marketing and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit https://kelun-biotech.com/.

WUHU, China, Oct. 18, 2025 /PRNewswire/ — The global automotive industry is entering a new era shaped by energy transformation and intelligent innovation. With continuous R&D investment and an open ecosystem, Chery has become a key driver of this transformation. On October 18, 2025, guided by a futuristic AI host, the Chery International Technology Night officially kicked off. More than a showcase of innovation, it marked a global initiative to co-create a new pathway for technology globalization and advance the future of intelligent mobility.

As a core event of the 2025 Chery International User Summit, the night carried the theme “CO-CREATE • CO-DEFINE.” Over 1,500 guests — including global media, dealers, suppliers, and key opinion consumers — joined the celebration. From a virtual AI host to intelligent robot greeters, immersive technology filled the entire experience, reflecting Chery’s belief that “Technology Drives the Future.”

Technological Leap: From 48% Thermal Efficiency to Comprehensive Innovation

At the Technology Night, Chery unveiled groundbreaking innovations that captured global attention. The new-generation Chery power, boasting an impressive 48% thermal efficiency, sets a new benchmark for hybrid energy performance. This breakthrough not only highlights Chery’s deep expertise in powertrain engineering but also signifies that China’s hybrid technologies have reached world-leading standards. In the field of intelligent mobility, Chery has leveraged insights from diverse global road conditions and user behaviors to optimize its intelligent driving systems. The result is enhanced localization and adaptability, offering users worldwide a smarter, more intuitive driving experience tailored to real-world needs.

Safety remains Chery’s uncompromising priority. By showcasing crash test results that exceed global benchmarks and deep collaborations with organizations such as ENCAP and IDIADA, Chery reaffirmed its commitment to the highest standards of occupant protection. To date, 51 Chery models have earned five-star safety ratings worldwide — the most among Chinese automotive brands. From structural engineering to material application, every “beyond-standard” safety detail reflects Chery’s vision to be the trusted global leader in intelligent mobility ecosystems.

Ecosystem Co-Creation: Defining New Standards, Empowering Global Markets

If breakthrough technologies are Chery’s flagship for global expansion, then an open ecosystem is its fleet. The most strategic highlight of the night was the launch of the Global Co-Creation & Joint Innovation Initiative, a high-value platform that goes beyond traditional supply chain partnerships — aiming to co-define future technology standards and empower global markets.

The initiative brings together leading global partners across hybrid, intelligent, and safety technologies, integrating regional standards and market needs into advanced R&D. Through this deep collaborative model, Chery aims to deliver globally adaptable and technologically advanced solutions, injecting fresh momentum into the evolution of the global automotive industry.

Immersive Experience: AI and Chery’s “Doctor Team” Orchestrate a Symphony of Technology

To present its cutting-edge technologies in a more engaging way, Chery designed an immersive event experience. A virtual AI host connected every segment of the show, infusing the evening with a strong sense of futurism and technological artistry.

Guided by the AI host, nine of Chery’s top technical experts, led by Dr. Gao Xinhua, took the stage as the “Doctor Team.” They offered in-depth insights across three key dimensions — hybrid, intelligent, and safety technologies. More than engineers, they served as ambassadors of Chery’s innovation DNA, reinforcing the credibility of the “Technology Chery” brand with their expertise and real-world data. The session concluded with testimonials from global endurance test participants and users, bridging the gap between theory and real-world application — a compelling validation of trust built from the lab to everyday life.

Setting Sail: Guided by Users, Navigating Toward a Broader Future

The evening reached its climax with the Chery International “Technology Fleet” Expedition Ceremony. As company leaders jointly turned the ship’s helm, it symbolized Chery’s commitment to embarking on a new era of global expansion — together with its partners and users worldwide as one powerful “technology fleet.”

As the saying goes, “If you want to go fast, go alone; if you want to go far, go together.” The trust of 17.72 million users worldwide stands as the greatest testament to Chery’s “co-creation with users” philosophy. In his closing remarks, Mr. Zhang Guibing, General Manager of Chery International Business Division, emphasized that users are an indispensable part of Chery’s global community — their voices and needs continue to guide Chery’s technological evolution and product innovation.

Looking ahead, the Chery International Technology Night sent a clear message to the world: Chery is setting sail with technology as its sail, ecosystem as its oar, and users as its compass — steadfastly navigating toward a new global mobility landscape. This new voyage belongs not only to Chery, but also to every global partner and user who shares in this great transformation of the mobility era.